“During breastfeeding, the TDF (tenofovir disoproxil fumarate)-containing ART regimen had no observed adverse impact on maternal renal function,” the authors wrote. “However, continued monitoring to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results